Cardinal Health (NYSE:CAH - Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 9.100-9.300 for the period, compared to the consensus earnings per share estimate of 9.130. The company issued revenue guidance of -.
Cardinal Health Stock Up 4.5%
Shares of CAH traded up $6.90 during trading hours on Thursday, reaching $160.43. 2,968,015 shares of the company traded hands, compared to its average volume of 2,225,422. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $161.07. The company's fifty day moving average price is $145.31 and its two-hundred day moving average price is $132.35. The company has a market capitalization of $38.29 billion, a price-to-earnings ratio of 29.93, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter last year, the business posted $2.08 EPS. On average, analysts expect that Cardinal Health will post 7.95 EPS for the current year.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.27%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on CAH. Citigroup restated a "neutral" rating on shares of Cardinal Health in a research note on Thursday, May 1st. Wells Fargo & Company raised shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $136.00 to $179.00 in a research report on Tuesday, June 3rd. UBS Group lifted their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Evercore ISI increased their price target on shares of Cardinal Health from $175.00 to $180.00 and gave the company an "outperform" rating in a report on Thursday. Finally, Robert W. Baird raised their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $153.43.
Check Out Our Latest Analysis on Cardinal Health
Institutional Investors Weigh In On Cardinal Health
A hedge fund recently raised its stake in Cardinal Health stock. Integrated Wealth Concepts LLC increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,363 shares of the company's stock after purchasing an additional 280 shares during the quarter. Integrated Wealth Concepts LLC's holdings in Cardinal Health were worth $601,000 at the end of the most recent reporting period. 87.17% of the stock is owned by institutional investors.
Cardinal Health Company Profile
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
